Differences in gene expression profiles and signaling pathways in rhabdomyolysis-induced acute kidney injury

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 11, 2015, Pages 14087-14098

  Geng, Xiaodong ^a   Wang, Yuanda ^a   Hong, Quan ^a   Yang, Jurong ^b   Zheng, Wei ^a   Zhang, Gang ^c   Cai, Guangyan ^a   Chen, Xiangmei ^a   Wu, Di ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Acute kidney injury; Gene expression profile; Rhabdomyolysis; Signal pathway

Indexed keywords

GLYCEROL;

ACUTE KIDNEY FAILURE; ANIMAL; BIOLOGY; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; MALE; METABOLISM; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOLYSIS; SIGNAL TRANSDUCTION;

ACUTE KIDNEY INJURY; ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GLYCEROL; MALE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOLYSIS; SIGNAL TRANSDUCTION;

EID: 85013249548     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49: 314-326.
2. Dayer-Berenson L. Rhabdomyolysis: a comprehensive guide. ANNA J 1994; 21: 15-18; quiz 19-20.
3. Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem 2000; 37: 581-587.
4. Chedru MF, Baethke R and Oken DE. Renal cortical blood flow and glomerular filtration in myohemoglobinuric acute renal failure. Kidney Int 1972; 1: 232-239.
5. Cox JW, Baehler RW, Sharma H, O'Dorisio T, Osgood RW, Stein JH and Ferris TF. Studies of the mechanism of oliguria in a model of unilateral acute renal failure. J Clin Invest 1974; 53: 1546-1558.
6. Khan FY. Rhabdomyolysis: a review of the literature. Neth J Med 2009; 67: 272-283.
7. Twardowski ZJ. Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance. Blood Purif 2007; 25: 90-98.
8. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, Leunissen KM, Laurent G and Bergstrom J. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999; 14: 369-375.
9. Boutaud O and Roberts LJ 2nd. Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure. Free Radic Biol Med 2011; 51: 1062-1067.
10. Fahling M, Mathia S, Paliege A, Koesters R, Mrowka R, Peters H, Persson PB, Neumayer HH, Bachmann S and Rosenberger C. Tubular von Hippel-Lindau knockout protects against rhabdomyolysis-induced AKI. J Am Soc Nephrol 2013; 24: 1806-1819.
11. Wright GW and Simon RM. A random variance model for detection of differential gene expression in small microarray experiments. Bioin-formatics 2003; 19: 2448-2455.
12. Yang H, Crawford N, Lukes L, Finney R, Lancaster M and Hunter KW. Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis 2005; 22: 593-603.
13. Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA and Wang Y. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat Rev Cancer 2008; 8: 37-49.
14. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM and Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29.
15. Kanehisa M, Goto S, Kawashima S, Okuno Y and Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32: D277-280.
16. Yi M, Horton JD, Cohen JC, Hobbs HH and Stephens RM. Whole Pathway Scope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics 2006; 7: 30.
17. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C and Romero R. A systems biology approach for pathway level analysis. Genome Res 2007; 17: 1537-1545.
18. Jansen R, Greenbaum D and Gerstein M. Relating whole-genome expression data with protein-protein interactions. Genome Res 2002; 12: 37-46.
19. Li C and Li H. Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 2008; 24: 1175-1182.
20. Wei Z and Li H. A Markov random field model for network-based analysis of genomic data. Bioinformatics 2007; 23: 1537-1544.
21. Zhang JD and Wiemann S. KEGG graph: a graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics 2009; 25: 1470-1471.
22. Spirin V and Mirny LA. Protein complexes and functional modules in molecular networks. Proc Natl Acad Sci U S A 2003; 100: 12123-12128.
23. Parekh R, Care DA and Tainter CR. Rhabdomyolysis: advances in diagnosis and treatment. Emerg Med Pract 2012; 14: 1-15; quiz 15.
24. Kim JH, Lee SS, Jung MH, Yeo HD, Kim HJ, Yang JI, Roh GS, Chang SH and Park DJ. N-acetylcysteine attenuates glycerol-induced acute kidney injury by regulating MAPKs and Bcl-2 family proteins. Nephrol Dial Transplant 2010; 25: 1435-1443.
25. Heyman SN, Lieberthal W, Rogiers P and Bonventre JV. Animal models of acute tubular necrosis. Curr Opin Crit Care 2002; 8: 526-534.
26. Bosch X, Poch E and Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009; 361: 62-72.
27. Anakk S, Kalsotra A, Shen Q, Vu MT, Staudinger JL, Davies PJ and Strobel HW. Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptors. FASEB J 2003; 17: 1736-1738.
28. Brocker C, Lassen N, Estey T, Pappa A, Cantore M, Orlova VV, Chavakis T, Kavanagh KL, Oppermann U and Vasiliou V. Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperos motic stress. J Biol Chem 2010; 285: 18452-18463.
29. Chen LF and Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 2004; 5: 392-401.
30. Guijarro C and Egido J. Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 2001; 59: 415-424.
31. Weston CR, Lambright DG and Davis RJ. Signal transduction. MAP kinase signaling specificity. Science 2002; 296: 2345-2347.
32. Li L, Gao Y, Zhang L, Zeng J, He D and Sun Y. Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma. Cancer Lett 2008; 272: 61-69.
33. Takano Y, Iwata H, Yano Y, Miyazawa M, Virgona N, Sato H, Ueno K and Yano T. Up-regulation of connexin 32 gene by 5-aza-2'-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling. Biochem Pharmacol 2010; 80: 463-470.
34. Wooten RM and Weis JJ. Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. Curr Opin Microbiol 2001; 4: 274-279.
35. Lin M and Rikihisa Y. Ehrlichia chaffeensis downregulates surface Toll-like receptors 2/4, CD14 and transcription factors PU.1 and inhibits lipopolysaccharide activation of NF-kappa B, ERK 1/2 and p38 MAPK in host monocytes. Cell Microbiol 2004; 6: 175-186.
36. Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S and Ronai Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 2007; 11: 447-460.
37. Kim YK, Kim HJ, Kwon CH, Kim JH, Woo JS, Jung JS and Kim JM. Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells. J Appl Toxicol 2005; 25: 374-382.
38. Tseng SH, Wang CH, Lin SM, Chen CK, Huang HY and Chen Y. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells. J Cancer Res Clin Oncol 2004; 130: 285-293.
39. Dhanasekaran DN and Reddy EP. JNK signaling in apoptosis. Oncogene 2008; 27: 6245-6251.
40. Liu J, Minemoto Y and Lin A. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 2004; 24: 10844-10856.
41. Takahashi H, Ogata H, Nishigaki R, Broide DH and Karin M. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta-and JNK1-dependent inflammation. Cancer Cell 2010; 17: 89-97.
42. Donovan N, Becker EB, Konishi Y and Bonni A. JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem 2002; 277: 40944-40949.
43. Tsuruta F, Sunayama J, Mori Y, Hattori S, Shimizu S, Tsujimoto Y, Yoshioka K, Masuyama N and Gotoh Y. JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 2004; 23: 1889-1899.
44. Han JY, Jeong EY, Kim YS, Roh GS, Kim HJ, Kang SS, Cho GJ and Choi WS. C-jun N-terminal kinase regulates the interaction between 14-3-3 and Bad in ethanol-induced cell death. J Neurosci Res 2008; 86: 3221-3229.
45. Gorospe M, Wang X and Holbrook NJ. Functional role of p21 during the cellular response to stress. Gene Expr 1999; 7: 377-385.
46. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH and Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3: 245-252.
47. Heliez C, Baricault L, Barboule N and Valette A. Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells. Oncogene 2003; 22: 3260-3268.
48. Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E and Los M. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 2007; 10: 13-29.
49. Sussman M. "AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. Trends Cardiovasc Med 2007; 17: 235-240.
50. Homsi E, Janino P and de Faria JB. Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure. Kidney Int 2006; 69: 1385-1392.
51. Wei Q, Hill WD, Su Y, Huang S and Dong Z. Heme oxygenase-1 induction contributes to renoprotection by G-CSF during rhabdomyolysis-associated acute kidney injury. Am J Physiol Renal Physiol 2011; 301: F162-170.
52. Wang B, Shravah J, Luo H, Raedschelders K, Chen DD and Ansley DM. Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem Biophys Res Commun 2009; 389: 105-111.
53. Kimura R, Okouchi M, Fujioka H, Ichiyanagi A, Ryuge F, Mizuno T, Imaeda K, Okayama N, Kamiya Y, Asai K and Joh T. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience 2009; 162: 1212-1219.
54. Matsuzawa A and Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal 2005; 7: 472-481.
55. Amaravadi R and Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 2005; 115: 2618-2624.
56. Song G, Ouyang G and Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005; 9: 59-71.